Turn Therapeutics Inc.

8-K Regulation FD disclosure Jul 28, 2026 8-K Regulation FD disclosure Jul 7, 2026 8-K Regulation FD disclosure Jun 3, 2026 8-K Regulation FD disclosure Jun 1, 2026 8-K Regulation FD disclosure May 27, 2026 8-K Regulation FD disclosure May 19, 2026 8-K Regulation FD disclosure May 18, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Mar 24, 2026 8-K Regulation FD disclosure Feb 17, 2026 8-K Regulation FD disclosure Feb 9, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Director or officer change; Regulation FD disclosure Jan 7, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Regulation FD disclosure Nov 12, 2025 8-K Regulation FD disclosure Nov 4, 2025 8-K Regulation FD disclosure Oct 30, 2025 8-K Entered a material agreement Oct 28, 2025 8-K Regulation FD disclosure Oct 22, 2025 8-K Entered a material agreement; Modified rights of security holders; Director or officer change; Amended charter or bylaws Oct 2, 2025 4 Jun 8, 2026 4 Jun 8, 2026 4 Jun 8, 2026 4 Jun 8, 2026 4 Jun 1, 2026 C-TR May 13, 2026 SCHEDULE 13G Apr 6, 2026 4 Apr 3, 2026 4 Apr 3, 2026 4 Apr 3, 2026 4 Apr 3, 2026 EFFECT Apr 2, 2026 EFFECT Apr 2, 2026 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 Mar 31, 2026 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 Mar 31, 2026 4 Feb 4, 2026